Search - tctmd.com

Displaying 1 - 20 of 68

Sort: Relevancy | Date

News Conference News TCT 2022

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

L.A. McKeown

September 23, 2022

News Conference News TCT 2022

PCSK9 Inhibitors Before PCI Swiftly Lower LDL-C in ACS Patients: EPIC-STEMI

Shelley Wood

September 22, 2022

News Conference News TCT 2022

Calcified Nodules Signal Worst Outcome Among OCT-Defined ACS Causes

Todd Neale

September 22, 2022

Presentation TCT 2022

Team-Based Management for STEMI/Shock: How Much Is Individual vs the Group

Presenter: Mir Basir

September 19, 2022

Presentation TCT 2022

Update From the AHA Expert Consensus Document: When/How to De-escalate MCS

Presenter: Ajar Kochar

September 19, 2022

Presentation TCT 2022

Update From the AHA Expert Consensus Document: When/How to Escalate MCS

Presenter: Gregory Serrao

September 19, 2022

News Conference News TCT 2022

SCAAR Registry Delves Into Left Main Revascularization Outcomes

Michael O'Riordan

September 19, 2022

Presentation TCT 2022

The Transformative Potential of Digital Health Strategies to Impact Clinical Research and Patient Outcomes

Presenter: Ami Bhatt

September 19, 2022

Presentation TCT 2022

The PERT Effect: How to Establish a Multdisciplinary Care Team for PE

Presenter: Sanjum Sethi

September 19, 2022

Presentation TCT 2022

Strengths and Limitations of Patient Reported Outcomes as Major Endpoints in "Modern Era" CV Trials

Presenter: Alexander Iribarne

September 19, 2022

News Conference News TCT 2022

Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances

Caitlin E. Cox

September 19, 2022

News Conference News TCT 2022

Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL

Yael L. Maxwell

September 19, 2022

Presentation TCT 2022

What Do the Guidelines Say?

Presenter: Celina Yong

September 19, 2022

Presentation TCT 2022

Come With Me If You Want to Survive: The Future of AI in Cardiology

Presenter: Pierre Elias

September 19, 2022

Not Yet – We Still Need Clinical Outcomes Data

Presentation TCT 2022

That’s Great But We Still Need Clinical Outcomes Data

Presenter: Ajay J. Kirtane

September 18, 2022

Presentation TCT 2022

It’s Time We Had These Devices Approved and Reimbursed

Presenter: David E. Kandzari

September 18, 2022

Presentation TCT 2022

Transformative Changes in Clinical Research: A Futurist’s Viewpoint

Presenter: C. Michael Gibson

September 18, 2022

Presentation TCT 2022

Health Equity Issues in Clinical Trials: Can We Accelerate Progress?

Presenter: Clyde Yancy

September 18, 2022

Presentation TCT 2022

Regulatory Innovation Revisited: Blending Patient Needs, Industry Imperatives, Health Policy, and Reimbursement

Presenter: Aaron Kaplan

September 18, 2022

Presentation TCT 2022

FDA Recovering From a Pandemic: Lessons Learned and Future Adjustments

Presenter: William Maisel

September 18, 2022

Advertisement

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

PCSK9 Inhibitors Before PCI Swiftly Lower LDL-C in ACS Patients: EPIC-STEMI

Calcified Nodules Signal Worst Outcome Among OCT-Defined ACS Causes

Team-Based Management for STEMI/Shock: How Much Is Individual vs the Group

Update From the AHA Expert Consensus Document: When/How to De-escalate MCS

Update From the AHA Expert Consensus Document: When/How to Escalate MCS

SCAAR Registry Delves Into Left Main Revascularization Outcomes

The Transformative Potential of Digital Health Strategies to Impact Clinical Research and Patient Outcomes

The PERT Effect: How to Establish a Multdisciplinary Care Team for PE

Strengths and Limitations of Patient Reported Outcomes as Major Endpoints in "Modern Era" CV Trials

Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances

Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL

What Do the Guidelines Say?

Come With Me If You Want to Survive: The Future of AI in Cardiology

That’s Great But We Still Need Clinical Outcomes Data

It’s Time We Had These Devices Approved and Reimbursed

Transformative Changes in Clinical Research: A Futurist’s Viewpoint

Health Equity Issues in Clinical Trials: Can We Accelerate Progress?

Regulatory Innovation Revisited: Blending Patient Needs, Industry Imperatives, Health Policy, and Reimbursement

FDA Recovering From a Pandemic: Lessons Learned and Future Adjustments

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content